Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001831218-26-000002

Options or other derivatives

  • PRESIDENT AND CEO acquired 1,125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bohen Sean PRESIDENT AND CEO 2026-02-02 Grant or award · Stock Option (Right to Buy) +850,000 850,000 D
Bohen Sean PRESIDENT AND CEO 2026-02-02 Grant or award · Performance Stock Options (Right to Buy) +275,000 275,000 D
Loading xslF345X05/form4-02042026_090201.xml…